Glutamate Receptors (Glutamate Receptor)

Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases.
Also Known As:
Glutamate Receptor; Receptors, Glutamate; Excitatory Amino Acid Receptor; Receptor, Glutamate; Excitatory Amino Acid Receptors; Receptors, Excitatory Amino Acid
Networked: 2141 relevant articles (36 outcomes, 232 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results


1. Takahashi, Yukitoshi: 43 articles (09/2014 - 06/2003)
2. Meador-Woodruff, James H: 12 articles (06/2013 - 06/2003)
3. Javitt, Daniel C: 11 articles (09/2012 - 12/2002)
4. Levite, Mia: 10 articles (08/2014 - 09/2004)
5. Krystal, John H: 9 articles (03/2015 - 07/2003)
6. Huganir, Richard L: 9 articles (09/2014 - 02/2004)
7. Ganor, Yonatan: 9 articles (08/2014 - 09/2004)
8. Vécsei, László: 8 articles (08/2014 - 09/2002)
9. Worley, Paul F: 8 articles (10/2013 - 02/2005)
10. Magazanik, L G: 8 articles (09/2013 - 09/2002)

Related Diseases

1. Ischemia
2. Seizures (Seizure)
09/01/2009 - "The results of our coordinated electrophysiological, receptor-pharmacological and histoblot studies demonstrated that repeated, daily, short convulsions resulted in a significant decrease of the general excitability of the somatosensory cortex together with changes in ionotropic glutamate receptor subunits. "
04/10/2003 - "As glutamate receptors are thought to participate in seizure induction and the subsequent neuronal degeneration that ensues, previous studies have proposed that variation in the precise subunit composition of glutamate receptors may result in differential susceptibility to excitotoxic cell death. "
11/26/2001 - "The goal of this study was to determine the age of onset of cognitive dysfunction and alterations in seizure susceptibility in rats subjected to recurrent neonatal seizures and the relation of this cognitive impairment to mossy fiber sprouting and expression of glutamate receptors. "
12/11/1999 - "This study shows that PBN specifically protects against anticholinesterase-induced seizures by reversible protection of AChE activity and not by the blockade of muscarinic or glutamate receptors, reactivation of AChE or scavenging of ROS. "
07/01/2013 - "The observed differential transcriptional responses may contribute to early-life seizure-induced pre-conditioning and neuroprotection by reducing glutamate receptor-mediated Ca(2+) permeability of the hippocampus and redirecting inflammatory and apoptotic pathways. "
Order ALL the reference details at left...
3. Pain (Aches)
4. Parkinson Disease (Parkinson's Disease)
5. Schizophrenia (Dementia Praecox)

Related Drugs and Biologics

1. N-Methylaspartate (NMDA)
2. alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
3. Messenger RNA (mRNA)
4. Glutamic Acid (Glutamate)
5. AMPA Receptors (AMPA Receptor)
6. Dopamine (Intropin)
7. Amantadine (Aman)
8. Diazepam (Valium)
9. Kainic Acid (Kainate)
10. Dizocilpine Maleate (Dizocilpine)

Related Therapies and Procedures

1. Injections
2. Ligation
3. Intramuscular Injections
4. Oral Administration
5. Therapeutics

blog comments powered by Disqus
for Ischemia,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 3699 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>